Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-25 @ 8:24 PM
Study NCT ID:
NCT02314169
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-29
First Post:
2014-12-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03-21
Completion Date Type:
ESTIMATED
First Submit Date:
2014-12-10
First Submit QC Date:
None
Study First Post Date:
2014-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-26
Last Update Post Date:
2025-04-29
Last Update Post Date Type:
ACTUAL